Category: Stem Cell Research

Press release distribution, EDGAR filing, XBRL, regulatory filings

Acclaimed designer and longtime –Biotechnology enterprise Nature Cell started to recruit patients for its clinical trials of ‘ASTROSTEM,’ a stem cell drug for Alzheimer’s disease treatment, at … )–RMR Real Estate Income Fund today announced its regular quarterly distribution to common shareholders. The distribution of $0.33 per common share wil… )–The National Institute for Pharmaceutical Technology and Education welcomes Texas A&M Irma Lerma Rangel College of Pharmacy to the organization as its 17th… )–Leading programmatic, RTB, and machine learning technology company, IPONWEB, hires Jana Jakovljevic as VP of Business Development for North America.

Diabetes drug may be effective against deadly form of breast cancer, study suggests

Researchers in China have discovered that a metabolic enzyme called AKR1B1 drives an aggressive type of breast cancer . The study, “AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program,” which has been published in The Journal of Experimental Medicine , suggests that an inhibitor of this enzyme currently used to treat diabetes patients could be an effective therapy for this frequently deadly form of cancer .

First Cancer Patient Treated In Phase I/II Trial of ApoGrafta

Cellect Biotechnology Ltd. , a developer of stem cells selection technology, today announces that it has treated the first blood cancer patient in the recently initiated Phase I/II trial of its stem cell technology ApoGraftTM. The trial is intended to assess the Cellect ApoGraftTM process which is designed to prevent Graft-versus-Host Disease , a common complication associated with stem cell transplant in which the transplanted immune cells attack the recipient’s body cells and organs.

BioRestorative Therapies Receives FDA Clearance to Initiate Phase 2…

BioRestorative Therapies, Inc. , a life sciences company focused on stem cell-based therapies, today announced that it has received clearance by the U.S. Food and Drug Administration to commence a Phase 2 clinical trial using its lead cell therapy candidate, BRTX-100, to treat chronic lower back pain due to degenerative disc disease related to protruding/bulging discs. The Phase 2 clinical trial is a 72 patient, randomized, double-blind, controlled, multi-center study designed to evaluate safety and efficacy of a single dose of BRTX-100 in treating chronic lower lumbar disc disease.

Cyclophosphamide vs salvage chemotherapy plus G-CSF as…

Autologous hematopoietic stem cell transplantation is the standard treatment option for multiple myeloma and relapsed non-Hodgkin’s lymphoma patients. 2 Chemo-mobilization success depends on the patient’s age, apheresis timing, chemotherapy and immunomodulatory regimens as well as chemotherapy-related adverse events .

First stem cell study could lead to development of therapy to reduce inflammation caused by CF

A 39-year-old man with cystic fibrosis made history by becoming the first person to receive human adult stem cells in a new research study that researchers hope will someday lead to the development of a therapy to reduce the inflammation and infection caused by CF. The pioneering subject in the study is Bob Held from Alliance, Ohio, who on Jan. 26 received an infusion of cells called allogeneic human mesenchymal stem cells , adult stem cells collected from the bone marrow of healthy volunteers.

Islets from rat-grown mouse pancreases can help reverse disease in diabetic mice

Mouse pancreases grown in rats generate functional, insulin-producing cells that can reverse diabetes when transplanted into mice with the disease, according to researchers at the Stanford University School of Medicine and the Institute of Medical Science at the University of Tokyo. The recipient animals required only days of immunosuppressive therapy to prevent rejection of the genetically matched rather than lifelong treatment.

Islets from rat-grown mouse pancreases can help reverse disease in diabetic mice

Mouse pancreases grown in rats generate functional, insulin-producing cells that can reverse diabetes when transplanted into mice with the disease, according to researchers at the Stanford University School of Medicine and the Institute of Medical Science at the University of Tokyo. The recipient animals required only days of immunosuppressive therapy to prevent rejection of the genetically matched rather than lifelong treatment.

Scientist Alan Mackay-Sim is Australian of the Year 2017

Australian of the Year 2017 is Alan Mackay-Sim: Scientist whose stem cell research is helping to repair damaged spinal cords wins national award Biomedical scientist Alan Mackay-Sim, whose research has been hailed ‘more impressive than man walking on the moon’, has been named the 2017 Australian of the Year. The Queensland-based professor has dedicated his life to pioneering stem cell research and its use in repairing damaged spinal cords, including helping to restore mobility in a quadriplegic man.

Study finds cutting calories may help monkeys live longer

A 2009 image of rhesus monkeys in a landmark study of the benefits of caloric restriction. The then 27-year-old monkey on the left was given a diet with fewer calories while the 29-year-old monkey on the right was allowed to eat as much as it liked.A new study of the effects of a restricted diet reinforces the idea that reducing caloric intake has health benefits that can extend lifespan.

Cell-Free Embryonic Stem Cell Extract-Mediated Derivation of…

The oocyte-independent source for the generation of pluripotent stem cells is among the ultimate goals in regenerative medicine. We report that on exposure to mouse embryonic stem cell extracts, reversibly permeabilized NIH3T3 cells undergo dedifferentiation followed by stimulus-induced redifferentiation into multiple lineage cell types.

Flood of News Presents Buying Opportunity

… 5 million and 6 million patients. Beyond the FDA, word just came in from the Paul Ehrlich Institute, Germany’s health regulator, that the same trial could begin enrollment there. Though the trial will be enrolling 250 patients globally, approval is …

Cellect Receives Patent Notice of Allowance from US Patent &…

Cellect Biotechnology Ltd. , a developer of stem cells isolation technology, announces today that it has received a formal notice of allowance around a key method of treatment patent from the United States Patent & Trademark Office. The allowed claims relate to the engineering of regulatory immune cells with enhanced apoptotic activity to be used for immunomodulation for treating or preventing immune related disorders.

Research suggests the stem cells in our teeth can be energized to fill in chips, cracks, and cavities

The stem cells in our teeth can be energized to fill in chips, cracks, and cavities, researchers say, and the findings could one day possibly make dental cement obsolete. The work has been conducted just in mice so far, but the research , published Monday in the journal Scientific Reports, highlights a way to motivate stem cells to repair tooth defects at a scale they normally can’t, with a drug that already has some safety testing behind it.

All my children call the centre ‘Our Maggie’s’

But last year the father-of-five discovered that he is also one in 500, after being diagnosed with a rare blood cancer called mantle cell lymphoma. Before his diagnosis in November, Andrew was the fittest he had been in years, after giving up booze and losing three stone through his passion for cycling.

Postdoctoral Fellow Positions Available

Postdoctoral fellow positions in neuroscience are available at the Department of Neurosurgery in the State University of New York Upstate Medical University in the . We are looking for highly motivated postdocs with experience in both in vivo and in vitro to join our research team for performing US federal government funded research projects.